CN105395983A - Facial erysipelas treating applying powder - Google Patents
Facial erysipelas treating applying powder Download PDFInfo
- Publication number
- CN105395983A CN105395983A CN201410469064.6A CN201410469064A CN105395983A CN 105395983 A CN105395983 A CN 105395983A CN 201410469064 A CN201410469064 A CN 201410469064A CN 105395983 A CN105395983 A CN 105395983A
- Authority
- CN
- China
- Prior art keywords
- parts
- applying powder
- facial
- facial erysipelas
- erysipelas treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to facial erysipelas treating applying powder, and belongs to the technical field of traditional Chinese medicine preparations, wherein the facial erysipelas treating applying powder mainly comprises six bulk drugs such as wild chrysanthemum, radix paeoniae rubra, pulsatilla chinensis, saposhnikovia divaricat and the like, and the bulk drugs are prepared into applying powder for external application by using pharmaceutical equipment. The facial erysipelas treating applying powder of the present invention has functions of heat clearing, dampness removing, blood circulation activating, stasis removing and detoxification, and further has characteristics of good facial erysipelas treating effect, convenient applying, safety, and effectiveness.
Description
Technical field
The invention belongs to technical field of traditional Chinese medicine preparation.
Background technology
Facial area erysipelas betides human body facial area, and erythema appears in affected part, inflamed papules, and bunch integrated group, develops into blister, innumerable as beading, is arranged in string-like.Class's rash is just transparent, within 5-6 days, turns muddy.The course of disease about 2-4 week.Modern medicine is at present to the not yet special effective Therapeutic Method for the treatment of of this card.
Summary of the invention
The object of the invention is to overcome the deficiencies in the prior art, a kind of face powder for the treatment of facial area erysipelas is provided.It has clearing away heat-damp and promoting diuresis, the function of blood circulation promoting and blood stasis dispelling removing toxic substances, and treatment facial area erysipelas is effective.Can reach to flutter spreads conveniently, object safely and effectively.
The technical solution adopted for the present invention to solve the technical problems is: be made up of Flos Chrysanthemi Indici, Flos Lonicerae, Radix Paeoniae Rubra, Rhizoma Smilacis Glabrae, Radix Saposhnikoviae, the Radix Pulsatillae 6 kinds of crude drug.
About ingredient major function and preparation in invention formulation.
Flos Chrysanthemi Indici in the present invention, nature and flavor are bitter, pungent, are slightly cold.Heat-clearing and toxic substances removing.Cure mainly carbuncle, furunculosis, laryngopharynx swelling and pain, wind-fire acute conjunctivitis, skin pruritus.
Flos Lonicerae in the present invention, nature and flavor are sweet, cold.Containing Flos Lonicerae glycoside, luteolin, inositol, Saponin etc.Heat-clearing and toxic substances removing.Cure mainly epidemic febrile disease heating, carbuncle, scabies, malignant boil, toxic swelling, toxic-heat and blood stasis, pneumonia, laryngopharynx swelling and pain, anemopyretic cold etc.
Radix Paeoniae Rubra in the present invention, nature and flavor are sour, bitter, are slightly cold.Containing benzoic acid, paeoniflorin, starch, tannin, resin, phlegmatic temperament, pigment etc.Removing blood stasis and activating blood flow, pain relieving, removing fire from the liver.Cure mainly menoxenia, the stasis of blood is stagnant, stomachache, amenorrhea, lump in the abdomen, skin sore, chest and hypochondrium, conjunctival congestion.
Rhizoma Smilacis Glabrae in the present invention, nature and flavor are sweet, light, flat.Containing steroid saponin, alkaloid, volatile oil, saccharide, tannin etc.Dampness removing, removing toxic substances.Cure mainly Fructus Myricae rubrae skin infection, muscles and bones spasm and pain, scrofula carbuncle, antimercurialism.
Radix Saposhnikoviae in the present invention, nature and flavor acrid, sweet, warm.Containing volatile oil, mannitol, phenolic substance and polysaccharide etc.Deliver, dispel the wind, victory is wet.Cure mainly affection of exogenous wind-cold, headache and dizziness, general aching, rheumatic arthralgia, extremity contraction is anxious.
The Radix Pulsatillae in the present invention, nature and flavor are bitter, cold.Containing Saponin, anemonin etc.Clearing away heat and cooling blood, analgesic antidotal.Cure mainly toxic-heat and blood stasis, epistaxis, internal hemorrhoid with bleeding.
The etiology and pathogenesis of facial area erysipelas is retention of damp-heat in the interior, qi depression to blood stasis, and malicious heresy is accumulate long-pending skin and formed.The present invention has clearing away heat-damp and promoting diuresis, the function of blood circulation promoting and blood stasis dispelling removing toxic substances, and treatment facial area erysipelas is effective.The invention has the beneficial effects as follows through clinical practice proof determined curative effect, safe without toxic side effect.
Detailed description of the invention
1. formula and part by weight: Flos Chrysanthemi Indici 30 parts, Flos Lonicerae 25 parts, Radix Paeoniae Rubra 15 parts, Rhizoma Smilacis Glabrae 30 parts, Radix Saposhnikoviae 18 parts, the Radix Pulsatillae 20 parts.
2. manufacture method: weighed in proportion by above-mentioned raw materials medicine and assort, it is qualified to concoct with pharmaceutical equipment apparatus, makes fine powder external and flutter and be spread on lesion after concentrated mix homogeneously of purifying.
Claims (1)
1. treat a face powder for facial area erysipelas, it is characterized in that formula and part by weight are Flos Chrysanthemi Indici 30 parts, Flos Lonicerae 25 parts, Radix Paeoniae Rubra 15 parts, Rhizoma Smilacis Glabrae 30 parts, Radix Saposhnikoviae 15 parts, the Radix Pulsatillae 20 parts; Weighed in proportion by above-mentioned raw materials medicine and assort, it is qualified to concoct with pharmaceutical equipment apparatus, makes fine powder external and flutter and be spread on lesion after concentrated mix homogeneously of purifying.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410469064.6A CN105395983A (en) | 2014-09-16 | 2014-09-16 | Facial erysipelas treating applying powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410469064.6A CN105395983A (en) | 2014-09-16 | 2014-09-16 | Facial erysipelas treating applying powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105395983A true CN105395983A (en) | 2016-03-16 |
Family
ID=55461970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410469064.6A Pending CN105395983A (en) | 2014-09-16 | 2014-09-16 | Facial erysipelas treating applying powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105395983A (en) |
-
2014
- 2014-09-16 CN CN201410469064.6A patent/CN105395983A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105878378A (en) | Traditional Chinese medicinal composition for treating rheumatic fever type psoriasis | |
| CN104095947A (en) | Traditional Chinese medicine preparation for treating scapulohumeral periarthritis | |
| CN105395983A (en) | Facial erysipelas treating applying powder | |
| CN105521082A (en) | Traditional Chinese medicinal preparation for treating eczema with syndrome of wind heat | |
| CN104096162A (en) | Medicine patch for treating scapulohumeral periarthritis | |
| CN104225100A (en) | Drug for treating knee osteoarthritis | |
| CN105395984A (en) | Facial erysipelas treating lotion | |
| CN105616551A (en) | External lotion for treating Chong and Conception channel disharmony type urticaria | |
| CN105878542A (en) | Chinese patent medicine for treating blood deficiency and wind dryness type psoriasis | |
| CN105878629A (en) | Rubbing powder for treating plantar wart | |
| CN105726665A (en) | Linimentum for treatment of blood deficiency and wind-dry type lichen planus | |
| CN105878377A (en) | Powder for treating itchy plane warts | |
| CN105395985A (en) | Facial erysipelas treating coating cream | |
| CN105616549A (en) | Ointment for treating rheumatic fever-type psoriasis | |
| CN105477199A (en) | Chinese patent medicine for treating liver-depression dryness-heat verruca plana | |
| CN105878585A (en) | Traditional Chinese medicine composition for treating facial erysipelas | |
| CN106266075A (en) | The medicine for the treatment of erysipelas in the lower part of the trunk | |
| CN105726709A (en) | Chinese herbal preparation for treating lichen planus with the syndrome of rheumatic fever | |
| CN108236692A (en) | A kind of oral liquid for treating the dry anemopyretic seborrheic dematitis of blood | |
| CN106138189A (en) | A kind of Chinese medicine preparation treating tinea alba | |
| CN105521083A (en) | Lotion for treating wind-heat type eczema | |
| CN106138343A (en) | A kind of hair washing water treating tinea alba | |
| CN106177435A (en) | The Chinese medicine preparation for the treatment of tinea unguium | |
| CN105878477A (en) | Traditional Chinese medicine preparation for treating blood-stasis type psoriasis | |
| CN105878820A (en) | Traditional Chinese medicine preparation for treating verruca plana with severe itching |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160316 |